Last reviewed · How we verify
CB-5339
At a glance
| Generic name | CB-5339 |
|---|---|
| Also known as | CB-5339 Tosylate |
| Sponsor | Cleave Therapeutics, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Testing the Safety of CB-5339 in Patients With Cancer (PHASE1)
- Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |